Rana H Refaey

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Molecular Docking

Metastatic Renal Cell Carcinoma

Neuropathic Pain

Top Venues

Future medicinal chemistry

ACS medicinal chemistry letters

This page only lists publications with an associated author ORCID identifier.

Publications

Mona F Said, Riham F George, Walid Fayed, Ahmed A F Soliman, Rana H Refaey
Investigations of new N 1 -substituted pyrazoles as anti-inflammatory and analgesic agents having COX inhibitory activity. Future medicinal chemistry 16 (4) (2024)
Mona F Said, Riham F George, Walid Fayed, Ahmed A F Soliman, Rana H Refaey
Investigations of new N 1 -substituted pyrazoles as anti-inflammatory and analgesic agents having COX inhibitory activity. Future medicinal chemistry 16 (4) (2024)
Mona F Said, Riham F George, Walid Fayed, Ahmed A F Soliman, Rana H Refaey
Investigations of new N 1 -substituted pyrazoles as anti-inflammatory and analgesic agents having COX inhibitory activity. Future medicinal chemistry (2024)
Mona F Said, Riham F George, Walid Fayed, Ahmed A F Soliman, Rana H Refaey
Investigations of new N 1 -substituted pyrazoles as anti-inflammatory and analgesic agents having COX inhibitory activity. Future medicinal chemistry 16 (4) (2024)
Manar R Mohamed, Walaa R Mahmoud, Rana H Refaey, Riham F George, Hanan H Georgey
Insight on Some Newly Synthesized Trisubstituted Imidazolinones as VEGFR-2 Inhibitors. ACS medicinal chemistry letters 15 (6) (2024)
Manar R Mohamed, Walaa R Mahmoud, Rana H Refaey, Riham F George, Hanan H Georgey
Insight on Some Newly Synthesized Trisubstituted Imidazolinones as VEGFR-2 Inhibitors. ACS medicinal chemistry letters 15 (6) (2024)